Event The Use of Medicines in the U.S. 2023 May 18, 2023 Video Global Trends in R&D 2023 Activity, Productivity, and Enablers Institute Report The Global Use of Medicines 2023 Outlook to 2027 Fact Sheet COVID-19 Continues to Impact Global Spending on Medicines Based on research in th...
May 18, 2023 Institute Report The Global Use of Medicines 2022 Institute Report The Use of Medicines in the U.S. 2022 Institute Report Optimizing Oncology Care Through Biomarker Adoption Institute Report Global Medicine Spending and Usage Trends Institute Report Biosimilars in the Unite...
The Chinese biosimilar industry has demonstrated rapid growth in recent years. Limited evidence is available about biosimilar uptake at the national level. This study aimed to assess biosimilar uptake in the case of trastuzumab and to explore potential f
The global expenditure on biological agents reached US$452 billion in 2022 [7], with more than 30% of total spending on medicines in European Union (EU) countries towards biological agents [8, 9]. High prices for oncology medicines are raising concerns about the sustainability of healthcare ...
In addition to this, the lack of palliative care facilities adds an extra burden for relatives of terminally ill cancer patients who require in-home care [4]. We believe that this is the first study to examine the availability, cost, and affordability of innovative cancer medicines in Morocco...
Science has made remarkable advances in understanding the molecular basis of disease, generating new and effective rationally-designed treatments at an accelerating rate. Ironically, the successes of science is creating a crisis in the affordability of e
Real-world data are also important to enhance understanding of the natural history of XLH and the impact of alternative treatments, to identify suitable participants to enrol in future clinical trials and studies and to plan healthcare services [22]. Global clinical practice recommendations for the ...
There were similar numbers of European (n = 56), Asian (n = 53), North American (n = 42) and global studies (n = 40) with smaller number of studies in other parts of the world (7 from Oceania, 2 from the Middle East and 1 from South America). A total of ...
This annual trend report from the IQVIA Institute quantifies the impact of market dynamics and examines the spending and usage of medicines in 2023 and the outlook to 2028, globally and for specific therapy areas and countries. This report is intended to
The Global Use of Medicines 2024: Outlook to 2028 Learn more Succeeding with Innovation: The State of Radioligand Therapy Readiness in Europe learn more Trends in Global Adult Vaccination: A View from Five Global Cities learn more Drug Shortages in the U.S. 2023 A closer look at volume...